Biosecurity Modernization and Innovation Act of 2026
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Email me when S 3741 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 3741. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the Secretary of Commerce to issue regulations that force companies that make or sell synthetic nucleic acids to screen orders and verify customers, and it establishes a system to assess compliance. It also creates a “sandbox” for testing new bio‑security tools and orders the OSTP director to review and streamline federal bio‑security oversight. The goal is to reduce the risk of misuse of gene‑synthesis technology while keeping U.S. biotech innovation competitive.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 3741
3 free questions a day, no accountHistory
- Read twice and referred to the Committee on Commerce, Science, and Transportation.
- Introduced in Senate
Sponsors
- Sen. Cotton, Tom [R-AR] (R) · sponsor
- Sen. Budd, Ted [R-NC] (R)
- Sen. Coons, Christopher A. [D-DE] (D)
- Sen. Hickenlooper, John W. [D-CO] (D)
- Sen. Klobuchar, Amy [D-MN] (D)
- Sen. McCormick, David [R-PA] (R)
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 3741 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 3741 freeOr ask your AI assistant about S 3741 directly:
Add to Claude, ChatGPT or Cursor